Letter to the editor: ROLE OF WDR5 IN BREAST CANCER PROGNOSIS

被引：0
|
作者：
Stoeber, Regina [1 ]
机构：
[1] Leibniz Res Ctr Working Environm & Human Factors, Ardeystr 67, D-44139 Dortmund, Germany
来源：
EXCLI JOURNAL | 2019年 / 18卷
关键词：
TUMOR-CELL MIGRATION; GENE-EXPRESSION; IMPACT;
D O I：
10.17179/excli2019-2062
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：1094 / 1096
页数：3
相关论文
共 50 条
  • [21] Wdr5 is essential for fetal erythropoiesis and hematopoiesis
    Lulu Liu
    Yanjia Fang
    Xiaodan Ding
    Weihua Zhou
    Remi Terranova
    Yan Zhang
    He Wang
    Experimental Hematology & Oncology, 12
  • [22] WDR5 REPRESENTS A THERAPEUTICALLY EXPLOITABLE TARGET FOR CANCER STEM CELLS IN GLIOBLASTOMA
    Mitchell, Kelly
    Sprowls, Samuel
    Shakya, Sajina
    Arora, Sonali
    Silver, Daniel
    Goins, Christopher
    Wallace, Lisa
    Roversi, Gustavo
    Schafer, Rachel
    Kay, Kristen
    Miller, Tyler
    Lauko, Adam
    Bassett, John
    Kashyap, Anjali
    Kass, J. D'Amato
    Mulkearns-Hubert, Erin
    Johnson, Sadie
    Alvarado, Joseph
    Rich, Jeremy
    Paddison, Patrick
    Patel, Anoop
    Stauffer, Shaun
    Hubert, Christopher
    Lathia, Justin
    NEURO-ONCOLOGY, 2023, 25
  • [23] Role of Wdr5 in Endochondral Bone Formation During Chicken Limb Development
    Zhu, S.
    Zhu, E.
    Provot, S.
    Gori, F.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S271 - S271
  • [24] WDR5 ORCHESTRATES CANCER CELL SELF RENEWAL IN Myc DRIVEN MEDULLOBLASTOMA
    Ghosh, Swati
    Venkataraman, Sujatha
    Birks, Diane
    Foreman, Nicholas
    Vibhakar, Rajeev
    NEURO-ONCOLOGY, 2016, 18 : 101 - 101
  • [25] Expression of WD Repeat Domain 5 (WDR5) is Associated with Progression and Reduced Prognosis in Papillary Thyroid Carcinoma
    Xu, Wenchao
    Wang, Lingling
    An, Ying
    Ye, Ling
    MEDICAL SCIENCE MONITOR, 2019, 25 : 3762 - 3770
  • [26] Defining the molecular context of MYC and WDR5 at chromatin
    Guarnaccia, Alissa D.
    Tansey, William P.
    CANCER RESEARCH, 2018, 78 (13)
  • [27] Impact of WIN site inhibitor on the WDR5 interactome
    Guarnaccia, Alissa D.
    Rose, Kristie L.
    Wang, Jing
    Zhao, Bin
    Popay, Tessa M.
    Wang, Christina E.
    Guerrazzi, Kiana
    Hill, Salisha
    Woodley, Chase M.
    Hansen, Tyler J.
    Lorey, Shelly L.
    Shaw, J. Grace
    Payne, William G.
    Weissmiller, April M.
    Olejniczak, Edward T.
    Fesik, Stephen W.
    Liu, Qi
    Tansey, William P.
    CELL REPORTS, 2021, 34 (03):
  • [28] Human WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation
    Cai, Wesley L.
    Chen, Jocelyn Fang-Yi
    Chen, Huacui
    Wingrove, Emily
    Kurley, Sarah J.
    Chan, Lok Hei
    Zhang, Meiling
    Arnal-Estape, Anna
    Zhao, Minghui
    Balabaki, Amer
    Li, Wenxue
    Yu, Xufen
    Krop, Ethan D.
    Dou, Yali
    Liu, Yansheng
    Jin, Jian
    Westbrook, Thomas F.
    Nguyen, Don X.
    Yan, Qin
    ELIFE, 2022, 11 : 1 - 76
  • [29] Exploring the kinetics of the Win-site of WDR5
    Imran, Ali
    Moyer, Brandon S.
    Canning, Ashley
    Kalina, Dan
    Duncan, Thomas
    Moody, Kelsey J.
    Wolfe, Aaron
    Cosgrove, Michael S.
    Movileanu, Liviu
    BIOPHYSICAL JOURNAL, 2022, 121 (03) : 54 - 54
  • [30] Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic
    Li, Dongxu
    Yu, Xufen
    Kottur, Jithesh
    Gong, Weida
    Zhang, Zhao
    Storey, Aaron J.
    Tsai, Yi-Hsuan
    Uryu, Hidetaka
    Shen, Yudao
    Byrum, Stephanie D.
    Edmondson, Rick D.
    Mackintosh, Samuel G.
    Cai, Ling
    Liu, Zhijie
    Aggarwal, Aneel K.
    Tackett, Alan J.
    Liu, Jing
    Jin, Jian
    Wang, Gang Greg
    ONCOGENE, 2022, 41 (24) : 3328 - 3340
12345